Literature DB >> 18600192

An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania.

Nurith Porat1, Carolina Soley, Marija M Marengolciene, David Greenberg, Noga Givon-Lavi, Ronit Trefler, Adriano Arguedas, Ron Dagan.   

Abstract

BACKGROUND: Serotype 3 is known for its ability to cause invasive diseases worldwide. In the United States, after introduction of the 7-valent pneumococcal conjugate vaccine (PCV7), the prevalence of a serotype 3 clone (Netherlands-31/ST180) increased. The present study was aimed to evaluate the importance of serotype 3 clones in noninvasive infections in Israel, Costa Rica, and Lithuania.
METHODS: Molecular typing and antibiotic resistance were performed on 77 serotype 3 strains recovered from pediatric noninvasive infections during 2003-2005, and on 50 carried strains from healthy carriers.
RESULTS: Serotype 3 ranked second among isolates from noninvasive infections in Costa Rica and Lithuania, and seventh among the Israeli isolates. Pulsed field gel electrophoresis (PFGE) analysis revealed the presence of 1 major cluster (64/77, 83%); this cluster comprised 60/64 fully susceptible strains that corresponded to the Netherlands-31/ST180 clone, and 4/64 multidrug-resistant strains, all from Lithuania, that corresponded to ST505, a double locus variant of ST180. Two additional fully susceptible clones, ST458 (11/77, 14%) and ST1116 (2/77, 3%), were found among the Israeli and Costa Rican strains, respectively. The same PFGE clusters identified among noninvasive infections were found among 50 isolates from carriers, with the same molecular characteristics.
CONCLUSIONS: Serotype 3 accounts for a large proportion of mucosal disease in children, even before the introduction of PCV7. The data presented here describe for the first time the importance of a multidrug-resistant serotype 3 clone, ST505, in noninvasive infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600192     DOI: 10.1097/INF.0b013e31816fca86

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; Amanda J Leach; James C Paton
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes.

Authors:  I Vickers; D O'Flanagan; M Cafferkey; H Humphreys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-13       Impact factor: 3.267

3.  Streptococcus pneumoniae Serotype 3 in Mexico (1994 to 2017): Decrease of the Unusual Clonal Complex 4909 Lineage following PCV13 Introduction.

Authors:  Gabriela Echániz-Aviles; Soraia I Guerreiro; Catarina Silva-Costa; Catarina I Mendes; João André Carriço; María Noemí Carnalla-Barajas; Araceli Soto-Noguerón; Maria Elena Velazquez-Meza; José Melo-Cristino; Antonio Luévanos-Velazquez; Lucía Martínez-Medina; María Del Rosario Vázquez-Larios; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

Review 4.  Paediatric pneumococcal disease in Central Europe.

Authors:  R Prymula; R Chlibek; I Ivaskeviciene; A Mangarov; Zs Mészner; P Perenovska; D Richter; N Salman; P Simurka; E Tamm; G Tešović; I Urbancikova; V Usonis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-11       Impact factor: 3.267

5.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

6.  Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing.

Authors:  Masahide Yano; Shruti Gohil; J Robert Coleman; Catherine Manix; Liise-anne Pirofski
Journal:  mBio       Date:  2011-11-01       Impact factor: 7.867

7.  Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines.

Authors:  Kedibone M Ndlangisa; Mignon du Plessis; Nicole Wolter; Linda de Gouveia; Keith P Klugman; Anne von Gottberg
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

8.  Properties of Mucoid Serotype 3 Streptococcus pneumoniae From Children in China.

Authors:  Ying Yang; Chun-Zhen Hua; Chao Fang; Yong-Ping Xie; Wei Li; Yong Fu; Feng Gao; Kai-Hu Yao
Journal:  Front Cell Infect Microbiol       Date:  2021-03-24       Impact factor: 5.293

9.  Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults.

Authors:  Alfonso Olaya-Abril; Irene Jiménez-Munguía; Lidia Gómez-Gascón; Ignacio Obando; Manuel J Rodríguez-Ortega
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.